Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM)

Last updated: May 10, 2026
Sponsor: Xiaoqin Luo
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neoplasms

Chemotherapy

Cancer

Treatment

N/A

Clinical Study ID

NCT06219083
2022-1373
  • Ages > 18
  • All Genders

Study Summary

This multicenter, prospective cohort study investigates the long-term impact of nutritional status on clinical outcomes in cancer patients undergoing treatment in Shaanxi Province, China. It evaluates how malnutrition, dietary patterns, and nutritional interventions affect treatment tolerance, quality of life, and survival. The study tracks dynamic changes in nutritional health and related indicators throughout various stages of chemoradiotherapy, aiming to inform evidence-based strategies for precision nutrition in oncology care.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults aged 18 years and above

  • Pathologically diagnosed with malignant tumors

  • Scheduled to undergo radiotherapy and/or chemotherapy

  • Clear consciousness, no communication barriers

  • Willing to undergo follow-up, not in a near-death condition

Exclusion

Exclusion Criteria:

  • Patients without a pathological diagnosis of malignant tumors

  • Patients with AIDS

  • Patients with mental or cognitive disorders

  • Patients who have undergone organ transplantation

  • Patients with a life expectancy less than 12 months

  • Pregnant women

  • Patients currently participating in other clinical intervention studies

Study Design

Total Participants: 1538
Study Start date:
November 12, 2020
Estimated Completion Date:
December 01, 2031

Study Description

Study Purpose and Objectives:

The Nutritional Status and Clinical Outcomes in Patients with Common Malignancies (NCOM) study aims to assess how nutritional status influences treatment-related complications, functional performance, psychosocial well-being, and long-term survival in cancer patients. By capturing longitudinal data, the study seeks to identify modifiable risk factors and develop predictive models to support personalized nutritional interventions in oncology.

Study Design and Scope:

The study is being conducted at 11 tertiary hospitals across Xi'an, Shaanxi Province, and will recruit a total of 1,538 patients diagnosed with common malignancies. Participants are enrolled within 48 hours of hospital admission and followed at structured intervals over a five-year period: at 1, 2, 3, 6, and 12 months, and then annually. Baseline and follow-up evaluations include demographic data, cancer-specific clinical characteristics, nutritional risk (mPG-SGA, NRS-2002), dietary intake (SDSAT), quality of life (EORTC QLQ-C30), psychosocial health (HADS), physical activity, sleep quality (PSQI), and laboratory biomarkers.

Data Collection and Management:

Standardized procedures are used for anthropometric measurements, clinical assessments, and patient-reported outcomes. Nutritional support in and out of hospital, inflammatory biomarkers, liver and kidney function, and hematological indicators are systematically recorded. All data are managed via REDCap with built-in validation, routine audits, and centralized oversight.

Quality Assurance and Training:

Research personnel at each site undergo rigorous training to ensure consistency in data collection and patient evaluation. Supervisors oversee data quality, coordinate follow-up, and address missing data or protocol deviations.

Ethical Oversight:

The study adheres to the Declaration of Helsinki and was approved by the Ethics Committee of Xi'an Jiaotong University Health Science Center (Approval No. 2022-1373). Written informed consent is obtained from all participants. All personal data are deidentified and securely stored.

Expected Outcomes and Significance:

By establishing the temporal relationships between nutritional status and clinical outcomes, the NCOM study will provide high-quality evidence to support individualized nutrition-focused care. Results are expected to improve early identification of patients at risk, optimize nutritional interventions, reduce treatment-related toxicity, and enhance long-term cancer prognosis.

Connect with a study center

  • Xi 'an Jiaotong University

    Xi'an, Shaanxi 710061
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.